Digital imaging in the immunohistochemical evaluation of the proliferation markers Ki67, MCM2 and Geminin, in early breast cancer, and their putative prognostic value

Comparison of PAM50 Risk of Recurrence Score With Oncotype DX and IHC4 for Predicting Risk of Distant Recurrence After Endocrine Therapy

(2013) Mitch Dowsett et al.   JOURNAL OF CLINICAL ONCOLOGY

The Use of Digital Images Improves Reproducibility of the Ki-67 Labeling Index as a Proliferation Marker in Breast Cancer

(2013) András Vörös et al.   PATHOLOGY & ONCOLOGY RESEARCH

The impact of comorbidity on cancer survival: a review

(2013) Mette Sogaard et al.   Clinical Epidemiology

Immunohistochemistry profiles of breast ductal carcinoma: factor analysis of digital image analysis data

(2012) Arvydas Laurinavicius et al.   Diagnostic Pathology

The manufacture and assessment of tissue microarrays: suggestions and criteria for analysis, with breast cancer as an example

(2012) Sarah E Pinder et al.   JOURNAL OF CLINICAL PATHOLOGY

Ki-67: level of evidence and methodological considerations for its role in the clinical management of breast cancer: analytical and critical review

(2011) Elisabeth Luporsi et al.   BREAST CANCER RESEARCH AND TREATMENT

Hallmarks of Cancer: The Next Generation

(2011) Douglas Hanahan et al.   CELL

Proliferative activity in human breast cancer: Ki-67 automated evaluation and the influence of different Ki-67 equivalent antibodies

(2011) S Fasanella et al.   Diagnostic Pathology

Prognostic Value of a Combined Estrogen Receptor, Progesterone Receptor, Ki-67, and Human Epidermal Growth Factor Receptor 2 Immunohistochemical Score and Comparison With the Genomic Health Recurrence Score in Early Breast Cancer

(2011) Jack Cuzick et al.   JOURNAL OF CLINICAL ONCOLOGY

Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group

(2011) M. Dowsett et al.   JNCI-Journal of the National Cancer Institute

Utility of oncotype DX risk estimates in clinically intermediate risk hormone receptor-positive, HER2-normal, grade II, lymph node-negative breast cancers

(2010) Catherine M. Kelly et al.   CANCER

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

(2010) Jacques Ferlay et al.   INTERNATIONAL JOURNAL OF CANCER

Ki67 in breast cancer: prognostic and predictive potential

(2010) Rinat Yerushalmi et al.   LANCET ONCOLOGY

Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2009

(2009) A. Goldhirsch et al.   ANNALS OF ONCOLOGY

Relationship between oestrogen receptor status and proliferation in predicting response and long-term outcome to neoadjuvant chemotherapy for breast cancer

(2009) Robin L. Jones et al.   BREAST CANCER RESEARCH AND TREATMENT

Complementary Value of the Ki-67 Proliferation Index to the Oncotype DX Recurrence Score

(2009) Katja Gwin et al.   INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY

Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer

(2009) Maggie C. U. Cheang et al.   JNCI-Journal of the National Cancer Institute

Tissue microarrays compared with whole sections and biochemical analyses. A subgroup analysis of DBCG 82 b&c.

(2008) M. Kyndi et al.   ACTA ONCOLOGICA

Cell cycle correlated genes dictate the prognostic power of breast cancer gene lists

(2008) Jonathan D Mosley et al.   BMC Medical Genomics